What companies are SLN's competitors?

Silence Therapeutics plc (SLN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does SLN compare to its peers?

The peer comparison table on this page shows Silence Therapeutics plc (SLN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does SLN operate in?

Silence Therapeutics plc (SLN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

SLN

Silence Therapeutics plc

NASDAQ·Biotechnology · Healthcare

$13.45$0.08−0.59%

Pre-market·$13.23−1.64%

Market cap$635.30M·Market closed·Aug 27 8:00 PM UTC

Frequently Asked Questions About SLN

What companies are SLN's competitors?: Silence Therapeutics plc (SLN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does SLN compare to its peers?: The peer comparison table on this page shows Silence Therapeutics plc (SLN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does SLN operate in?: Silence Therapeutics plc (SLN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

SLN

Silence Therapeutics plc

NASDAQ·Biotechnology · Healthcare

$13.45$0.08−0.59%

Pre-market·$13.23−1.64%

Market cap$635.30M·Market closed·Aug 27 8:00 PM UTC

Peers


ANRO	Alto Neuroscience, Inc.	$36.30	$1.3B
CTNM	Contineum Therapeutics, Inc.	$17.25	$649.0M
CAPR	Capricor Therapeutics, Inc.	$10.00	$575.1M
KYTX	Kyverna Therapeutics, Inc.	$8.64	$525.3M
LXEO	Lexeo Therapeutics, Inc. Common Stock	$4.99	$391.8M
LYEL	Lyell Immunopharma, Inc.	$14.61	$358.0M
AMRN	Amarin Corporation plc	$14.07	$291.0M
ACIU	AC Immune S.A.	$2.80	$284.5M
ALDX	Aldeyra The	$1.54	$92.9M
MREO	Mereo BioPharma Group plc	$0.27	$43.4M

Frequently Asked Questions About SLN

What companies are SLN's competitors?: Silence Therapeutics plc (SLN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does SLN compare to its peers?: The peer comparison table on this page shows Silence Therapeutics plc (SLN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does SLN operate in?: Silence Therapeutics plc (SLN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.